CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Johns Hopkins University
Baltimore, Estados UnidosJohns Hopkins University-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2024
-
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores
Neurology: Neuroimmunology and NeuroInflammation, Vol. 11, Núm. 5
2022
-
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
Multiple Sclerosis Journal, Vol. 28, Núm. 3, pp. 480-486
-
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 28, Núm. 9, pp. 1424-1456
2021
-
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
Multiple Sclerosis and Related Disorders, Vol. 47
2016
-
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study
The Lancet Neurology, Vol. 15, Núm. 6, pp. 574-584